BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Staudacher HM, Whelan K. The low FODMAP diet: Recent advances in understanding its mechanisms and efficacy in IBS. Gut. 2017;66:1517-1527. [PMID: 28592442 DOI: 10.1136/gutjnl-2017-313750] [Cited by in Crossref: 134] [Cited by in F6Publishing: 109] [Article Influence: 26.8] [Reference Citation Analysis]
Number Citing Articles
1 Hu Y, Heyer CME, Wang W, Zijlstra RT, Gänzle MG. Digestibility of branched and linear α-gluco-oligosaccharides in vitro and in ileal-cannulated pigs. Food Res Int 2020;127:108726. [PMID: 31882112 DOI: 10.1016/j.foodres.2019.108726] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
2 Xu B, Fu J, Qiao Y, Cao J, Deehan EC, Li Z, Jin M, Wang X, Wang Y. Higher intake of microbiota-accessible carbohydrates and improved cardiometabolic risk factors: a meta-analysis and umbrella review of dietary management in patients with type 2 diabetes. Am J Clin Nutr 2021;113:1515-30. [PMID: 33693499 DOI: 10.1093/ajcn/nqaa435] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
3 Tuck CJ, Biesiekierski JR, Schmid-Grendelmeier P, Pohl D. Food Intolerances. Nutrients 2019;11:E1684. [PMID: 31336652 DOI: 10.3390/nu11071684] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 9.3] [Reference Citation Analysis]
4 Orlando A, Tutino V, Notarnicola M, Riezzo G, Linsalata M, Clemente C, Prospero L, Martulli M, D'Attoma B, De Nunzio V, Russo F. Improved Symptom Profiles and Minimal Inflammation in IBS-D Patients Undergoing a Long-Term Low-FODMAP Diet: A Lipidomic Perspective. Nutrients 2020;12:E1652. [PMID: 32498383 DOI: 10.3390/nu12061652] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Paduano D, Cingolani A, Tanda E, Usai P. Effect of Three Diets (Low-FODMAP, Gluten-free and Balanced) on Irritable Bowel Syndrome Symptoms and Health-Related Quality of Life.Nutrients. 2019;11. [PMID: 31336747 DOI: 10.3390/nu11071566] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
6 Bellini M, Rossi A. Is a low FODMAP diet dangerous? Tech Coloproctol 2018;22:569-71. [PMID: 30083779 DOI: 10.1007/s10151-018-1835-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
7 Nybacka S, Störsrud S, Lindqvist HM, Törnblom H, Simrén M, Winkvist A. Habitual FODMAP Intake in Relation to Symptom Severity and Pattern in Patients with Irritable Bowel Syndrome. Nutrients 2020;13:E27. [PMID: 33374779 DOI: 10.3390/nu13010027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Staudacher HM, Scholz M, Lomer MC, Ralph FS, Irving PM, Lindsay JO, Fava F, Tuohy K, Whelan K. Gut microbiota associations with diet in irritable bowel syndrome and the effect of low FODMAP diet and probiotics. Clin Nutr 2021;40:1861-70. [PMID: 33183883 DOI: 10.1016/j.clnu.2020.10.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Camilleri M, Chedid V. Actionable biomarkers: the key to resolving disorders of gastrointestinal function. Gut 2020;69:1730-7. [DOI: 10.1136/gutjnl-2019-320325] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
10 Rexwinkel R, Vlieger AM, Saps M, Tabbers MM, Benninga MA. A therapeutic guide on pediatric irritable bowel syndrome and functional abdominal pain-not otherwise specified. Eur J Pediatr 2022. [PMID: 35460383 DOI: 10.1007/s00431-022-04459-y] [Reference Citation Analysis]
11 Whelan K, Martin LD, Staudacher HM, Lomer MCE. The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice. J Hum Nutr Diet 2018;31:239-55. [DOI: 10.1111/jhn.12530] [Cited by in Crossref: 97] [Cited by in F6Publishing: 74] [Article Influence: 24.3] [Reference Citation Analysis]
12 Tait C, Sayuk GS. The Brain-Gut-Microbiotal Axis: A framework for understanding functional GI illness and their therapeutic interventions. Eur J Intern Med 2021;84:1-9. [PMID: 33423906 DOI: 10.1016/j.ejim.2020.12.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
13 Panacer K, Whorwell PJ. Dietary Lectin exclusion: The next big food trend? World J Gastroenterol 2019; 25(24): 2973-2976 [PMID: 31293334 DOI: 10.3748/wjg.v25.i24.2973] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Biesiekierski JR, Tuck CJ. Low FODMAP diet beyond IBS: Evidence for use in other conditions. Current Opinion in Pharmacology 2022;64:102208. [DOI: 10.1016/j.coph.2022.102208] [Reference Citation Analysis]
15 Balmus I, Copolovici D, Copolovici L, Ciobica A, Gorgan DL. Biomolecules from Plant Wastes Potentially Relevant in the Management of Irritable Bowel Syndrome and Co-Occurring Symptomatology. Molecules 2022;27:2403. [DOI: 10.3390/molecules27082403] [Reference Citation Analysis]
16 Staudacher HM, Rossi M, Kaminski T, Dimidi E, Ralph FSE, Wilson B, Martin LD, Louis P, Lomer MCE, Irving PM, Whelan K. Long-term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndrome. Neurogastroenterol Motil 2021;:e14241. [PMID: 34431172 DOI: 10.1111/nmo.14241] [Reference Citation Analysis]
17 Brown SC, Whelan K, Gearry RB, Day AS. Low FODMAP diet in children and adolescents with functional bowel disorder: A clinical case note review. JGH Open 2020;4:153-9. [PMID: 32280758 DOI: 10.1002/jgh3.12231] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
18 Costa RJS, Gaskell SK, McCubbin AJ, Snipe RMJ. Exertional-heat stress-associated gastrointestinal perturbations during Olympic sports: Management strategies for athletes preparing and competing in the 2020 Tokyo Olympic Games. Temperature (Austin) 2020;7:58-88. [PMID: 32166105 DOI: 10.1080/23328940.2019.1597676] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 7.3] [Reference Citation Analysis]
19 Rossi M, Aggio R, Staudacher HM, Lomer MC, Lindsay JO, Irving P, Probert C, Whelan K. Volatile Organic Compounds in Feces Associate With Response to Dietary Intervention in Patients With Irritable Bowel Syndrome. Clin Gastroenterol Hepatol 2018;16:385-391.e1. [PMID: 28993261 DOI: 10.1016/j.cgh.2017.09.055] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 8.2] [Reference Citation Analysis]
20 Wang J, Yang P, Zhang L, Hou X. A Low-FODMAP Diet Improves the Global Symptoms and Bowel Habits of Adult IBS Patients: A Systematic Review and Meta-Analysis. Front Nutr 2021;8:683191. [PMID: 34490319 DOI: 10.3389/fnut.2021.683191] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Heenan PE, Keenan JI, Bayer S, Simon M, Gearry RB. Irritable bowel syndrome and the gut microbiota. Journal of the Royal Society of New Zealand 2020;50:470-90. [DOI: 10.1080/03036758.2019.1695635] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Yao CK, Chu NHS, Tan VPY. Breath Hydrogen Testing in East and Southeast Asia. Journal of Clinical Gastroenterology 2018;52:185-93. [DOI: 10.1097/mcg.0000000000000943] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Gupta S, Schaffer G, Saps M. Pediatric irritable bowel syndrome and other functional abdominal pain disorders: an update of non-pharmacological treatments. Expert Rev Gastroenterol Hepatol 2018;12:447-56. [PMID: 29633902 DOI: 10.1080/17474124.2018.1462699] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
24 Serrano-moreno C, Brox-torrecilla N, Arhip L, Romero I, Morales Á, Carrascal ML, Cuerda C, Motilla M, Camblor M, Velasco C, Bretón I. Diets for inflammatory bowel disease: What do we know so far? Eur J Clin Nutr. [DOI: 10.1038/s41430-021-01051-9] [Reference Citation Analysis]
25 Lin B, Wang Y, Zhang P, Yuan Y, Zhang Y, Chen G. Gut microbiota regulates neuropathic pain: potential mechanisms and therapeutic strategy. J Headache Pain 2020;21:103. [PMID: 32807072 DOI: 10.1186/s10194-020-01170-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
26 Oh H, Ehrenpreis ED, Tu FF, Dillane KE, Garrison EF, Leloudas N, Prasad PV, Hellman KM. Menstrual Cycle Variation in MRI-Based Quantification of Intraluminal Gas in Women With and Without Dysmenorrhea. Front Pain Res 2022;3:720141. [DOI: 10.3389/fpain.2022.720141] [Reference Citation Analysis]
27 Lajoie F, Rousseau G, Blanquet-Diot S, Etienne-Mesmin L. [Irritable bowel syndrome: Role of gut microbiota]. Med Sci (Paris) 2021;37:593-600. [PMID: 34180818 DOI: 10.1051/medsci/2021095] [Reference Citation Analysis]
28 Eswaran S, Farida JP, Green J, Miller JD, Chey WD. Nutrition in the management of gastrointestinal diseases and disorders: the evidence for the low FODMAP diet. Curr Opin Pharmacol. 2017;37:151-157. [PMID: 29156449 DOI: 10.1016/j.coph.2017.10.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
29 Mitchell H, Porter J, Gibson PR, Barrett J, Garg M. Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome-directions for future research. Aliment Pharmacol Ther. 2019;49:124-139. [PMID: 30589971 DOI: 10.1111/apt.15079] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 12.3] [Reference Citation Analysis]
30 Singh R, Zogg H, Ro S. Role of microRNAs in Disorders of Gut-Brain Interactions: Clinical Insights and Therapeutic Alternatives. J Pers Med 2021;11:1021. [PMID: 34683162 DOI: 10.3390/jpm11101021] [Reference Citation Analysis]
31 Mitchell A, England C, Perry R, Lander T, Shingler E, Searle A, Atkinson C. Dietary management for people with an ileostomy: a scoping review. JBI Evid Synth 2021;19:2188-306. [PMID: 34054034 DOI: 10.11124/JBIES-20-00377] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Mari A, Hosadurg D, Martin L, Zarate-Lopez N, Passananti V, Emmanuel A. Adherence with a low-FODMAP diet in irritable bowel syndrome: are eating disorders the missing link? Eur J Gastroenterol Hepatol. 2019;31:178-182. [PMID: 30543574 DOI: 10.1097/meg.0000000000001317] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
33 Kamphuis JBJ, Guiard B, Leveque M, Olier M, Jouanin I, Yvon S, Tondereau V, Rivière P, Guéraud F, Chevolleau S, Noguer-Meireles MH, Martin JF, Debrauwer L, Eutamène H, Theodorou V. Lactose and Fructo-oligosaccharides Increase Visceral Sensitivity in Mice via Glycation Processes, Increasing Mast Cell Density in Colonic Mucosa. Gastroenterology 2020;158:652-663.e6. [PMID: 31711923 DOI: 10.1053/j.gastro.2019.10.037] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
34 Cremon C, Barbaro MR, Ventura M, Barbara G. Pre- and probiotic overview. Curr Opin Pharmacol. 2018;43:87-92. [PMID: 30219638 DOI: 10.1016/j.coph.2018.08.010] [Cited by in Crossref: 43] [Cited by in F6Publishing: 25] [Article Influence: 10.8] [Reference Citation Analysis]
35 Herzlinger M, Cerezo C. Functional Abdominal Pain and Related Syndromes. Child and Adolescent Psychiatric Clinics of North America 2018;27:15-26. [DOI: 10.1016/j.chc.2017.08.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Chan MMH, Zarate-Lopez N, Martin L. Group education on the low FODMAP diet improves gastrointestinal symptoms but neither anxiety or depression in irritable bowel syndrome. J Hum Nutr Diet 2021. [PMID: 34705305 DOI: 10.1111/jhn.12951] [Reference Citation Analysis]
37 Liu Y, Xiao W, Yu L, Tian F, Wang G, Lu W, Narbad A, Chen W, Zhai Q. Evidence from comparative genomic analyses indicating that Lactobacillus-mediated irritable bowel syndrome alleviation is mediated by conjugated linoleic acid synthesis. Food Funct 2021;12:1121-34. [PMID: 33427835 DOI: 10.1039/d0fo02616f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Dimidi E, Rossi M, Whelan K. Irritable bowel syndrome and diet: where are we in 2018? Current Opinion in Clinical Nutrition & Metabolic Care 2017;20:456-63. [DOI: 10.1097/mco.0000000000000416] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
39 Dimidi E, Whelan K, Lomer MC. Investigating optimal education regarding the low FODMAP diet in functional bowel disorders: a feasibility randomised controlled trial of leaflet vs mobile application vs dietetic consultation. Proc Nutr Soc 2020;79. [DOI: 10.1017/s0029665119001289] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Requena T, Martínez-cuesta MC, Peláez C. Diet and microbiota linked in health and disease. Food Funct 2018;9:688-704. [DOI: 10.1039/c7fo01820g] [Cited by in Crossref: 71] [Cited by in F6Publishing: 34] [Article Influence: 17.8] [Reference Citation Analysis]
41 Holma R, Laatikainen R, Orell H, Joensuu H, Peuhkuri K, Poussa T, Korpela R, Österlund P. Consumption of Lactose, Other FODMAPs and Diarrhoea during Adjuvant 5-Fluorouracil Chemotherapy for Colorectal Cancer. Nutrients 2020;12:E407. [PMID: 32033152 DOI: 10.3390/nu12020407] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 De Filippis F, Vitaglione P, Cuomo R, Berni Canani R, Ercolini D. Dietary Interventions to Modulate the Gut Microbiome-How Far Away Are We From Precision Medicine. Inflamm Bowel Dis 2018;24:2142-54. [PMID: 29668914 DOI: 10.1093/ibd/izy080] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 13.0] [Reference Citation Analysis]
43 Chen Y, Wu G, Zhao Y. Gut Microbiota and Alimentary Tract Injury. Adv Exp Med Biol 2020;1238:11-22. [PMID: 32323177 DOI: 10.1007/978-981-15-2385-4_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Liang D, Longgui N, Guoqiang X. Efficacy of different probiotic protocols in irritable bowel syndrome: A network meta-analysis. Medicine (Baltimore) 2019;98:e16068. [PMID: 31277101 DOI: 10.1097/MD.0000000000016068] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
45 Hu M, Fang C, Liu Y, Gao M, Zhang D, Shi G, Yin Z, Zheng R, Zhang J. Comparative study of the laxative effects of konjac oligosaccharides and konjac glucomannan on loperamide-induced constipation in rats. Food Funct 2021;12:7709-17. [PMID: 34286775 DOI: 10.1039/d1fo01237a] [Reference Citation Analysis]
46 Gaskell SK, Taylor B, Muir J, Costa RJ. Impact of 24-h high and low fermentable oligo-, di-, monosaccharide, and polyol diets on markers of exercise-induced gastrointestinal syndrome in response to exertional heat stress. Appl Physiol Nutr Metab 2020;45:569-80. [DOI: 10.1139/apnm-2019-0187] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
47 Shutkever O, Gracie DJ, Young C, Wood HM, Taylor M, John Hamlin P, Ford AC, Quirke P. No Significant Association Between the Fecal Microbiome and the Presence of Irritable Bowel Syndrome-type Symptoms in Patients with Quiescent Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2018;24:1597-605. [DOI: 10.1093/ibd/izy052] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
48 Singh P, Grabauskas G, Zhou SY, Gao J, Zhang Y, Owyang C. High FODMAP diet causes barrier loss via lipopolysaccharide-mediated mast cell activation. JCI Insight 2021;6:e146529. [PMID: 34618688 DOI: 10.1172/jci.insight.146529] [Reference Citation Analysis]
49 Staudacher HM, Kurien M, Whelan K. Nutritional implications of dietary interventions for managing gastrointestinal disorders. Curr Opin Gastroenterol 2018;34:105-11. [PMID: 29278531 DOI: 10.1097/MOG.0000000000000421] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 3.7] [Reference Citation Analysis]
50 Barone M, Gemello E, Viggiani MT, Cristofori F, Renna C, Iannone A, Di Leo A, Francavilla R. Evaluation of Non-Celiac Gluten Sensitivity in Patients with Previous Diagnosis of Irritable Bowel Syndrome: A Randomized Double-Blind Placebo-Controlled Crossover Trial. Nutrients 2020;12:E705. [PMID: 32155878 DOI: 10.3390/nu12030705] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
51 Harper A, Naghibi MM, Garcha D. The Role of Bacteria, Probiotics and Diet in Irritable Bowel Syndrome. Foods 2018;7:E13. [PMID: 29373532 DOI: 10.3390/foods7020013] [Cited by in Crossref: 38] [Cited by in F6Publishing: 24] [Article Influence: 9.5] [Reference Citation Analysis]
52 Chu NHS, Yao CK, Tan VPY. Food Therapy in Sinosphere Asia. Journal of Clinical Gastroenterology 2018;52:105-13. [DOI: 10.1097/mcg.0000000000000932] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
53 Bao X, Wu J. Impact of food-derived bioactive peptides on gut function and health. Food Res Int 2021;147:110485. [PMID: 34399481 DOI: 10.1016/j.foodres.2021.110485] [Reference Citation Analysis]
54 Staudacher HM, Nevin AN, Duff C, Kendall BJ, Holtmann GJ. Epigastric symptom response to low FODMAP dietary advice compared with standard dietetic advice in individuals with functional dyspepsia. Neurogastroenterol Motil 2021;:e14148. [PMID: 33844408 DOI: 10.1111/nmo.14148] [Reference Citation Analysis]
55 Thirunathan P, Manickavasagan A. Processing methods for reducing alpha-galactosides in pulses. Critical Reviews in Food Science and Nutrition 2019;59:3334-48. [DOI: 10.1080/10408398.2018.1490886] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
56 Wu J, Masuy I, Biesiekierski JR, Fitzke HE, Parikh C, Schofield L, Shaikh H, Bhagwanani A, Aziz Q, Taylor SA, Tack J, Van Oudenhove L. Gut-brain axis dysfunction underlies FODMAP-induced symptom generation in irritable bowel syndrome. Aliment Pharmacol Ther 2022. [PMID: 35166384 DOI: 10.1111/apt.16812] [Reference Citation Analysis]
57 Ferraris RP, Choe JY, Patel CR. Intestinal Absorption of Fructose. Annu Rev Nutr 2018;38:41-67. [PMID: 29751733 DOI: 10.1146/annurev-nutr-082117-051707] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 10.3] [Reference Citation Analysis]
58 Valdes AM, Walter J, Segal E, Spector TD. Role of the gut microbiota in nutrition and health. BMJ. 2018;361:k2179. [PMID: 29899036 DOI: 10.1136/bmj.k2179] [Cited by in Crossref: 393] [Cited by in F6Publishing: 330] [Article Influence: 98.3] [Reference Citation Analysis]
59 Valdez-Palomares F, Nambo-Venegas R, Uribe-García J, Mendoza-Vargas A, Granados-Portillo O, Meraz-Cruz N, Palacios-González B. Intestinal microbiota fingerprint in subjects with irritable bowel syndrome responders to a low FODMAP diet. Food Funct 2021;12:3206-18. [PMID: 33877245 DOI: 10.1039/d0fo03162c] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Calasso M, Francavilla R, Cristofori F, De Angelis M, Gobbetti M. New Protocol for Production of Reduced-Gluten Wheat Bread and Pasta and Clinical Effect in Patients with Irritable Bowel Syndrome: A randomised, Double-Blind, Cross-Over Study. Nutrients. 2018;10:1873. [PMID: 30513824 DOI: 10.3390/nu10121873] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
61 Black CJ, Staudacher HM, Ford AC. Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut 2021:gutjnl-2021-325214. [PMID: 34376515 DOI: 10.1136/gutjnl-2021-325214] [Reference Citation Analysis]
62 Goll R, Johnsen PH, Hjerde E, Diab J, Valle PC, Hilpusch F, Cavanagh JP. Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut microbiome. Gut Microbes 2020;12:1794263. [PMID: 32991818 DOI: 10.1080/19490976.2020.1794263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Kim MY, Choi SW. Dietary modulation of gut microbiota for the relief of irritable bowel syndrome. Nutr Res Pract 2021;15:411-30. [PMID: 34349876 DOI: 10.4162/nrp.2021.15.4.411] [Reference Citation Analysis]
64 Ooi SL, Correa D, Pak SC. Probiotics, prebiotics, and low FODMAP diet for irritable bowel syndrome - What is the current evidence? Complement Ther Med 2019;43:73-80. [PMID: 30935559 DOI: 10.1016/j.ctim.2019.01.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
65 Menees S, Chey W. The gut microbiome and irritable bowel syndrome. F1000Res. 2018;7. [PMID: 30026921 DOI: 10.12688/f1000research.14592.1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 9.3] [Reference Citation Analysis]
66 Stenlund H, Nilholm C, Chorell E, Roth B, D'Amato M, Ohlsson B. Metabolic Profiling of Plasma in Patients with Irritable Bowel Syndrome after a 4-Week Starch- and Sucrose-Reduced Diet. Metabolites 2021;11:440. [PMID: 34357334 DOI: 10.3390/metabo11070440] [Reference Citation Analysis]
67 Yamashita LM, Corona LP, Dantas da Silva E, Monteiro de Mendonça AP, de Assumpção D, Barros Filho ADA, Barrett JS, Geloneze B, Vasques ACJ. FODMAP project: Development, validation and reproducibility of a short food frequency questionnaire to estimate consumption of fermentable carbohydrates. Clinical Nutrition 2021;40:3409-20. [DOI: 10.1016/j.clnu.2020.11.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Sugihara K, Morhardt TL, Kamada N. The Role of Dietary Nutrients in Inflammatory Bowel Disease. Front Immunol 2018;9:3183. [PMID: 30697218 DOI: 10.3389/fimmu.2018.03183] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 17.7] [Reference Citation Analysis]
69 Tuck CJ, Reed DE, Muir JG, Vanner SJ. Implementation of the low FODMAP diet in functional gastrointestinal symptoms: A real‐world experience. Neurogastroenterology & Motility 2019;32. [DOI: 10.1111/nmo.13730] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
70 Bouchoucha M, Fysekidis M, Rompteaux P, Raynaud JJ, Sabate JM, Benamouzig R. Lactose Sensitivity and Lactose Malabsorption: The 2 Faces of Lactose Intolerance. J Neurogastroenterol Motil 2021;27:257-64. [PMID: 33361550 DOI: 10.5056/jnm20094] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Tuck CJ, Vanner SJ. Dietary therapies for functional bowel symptoms: Recent advances, challenges, and future directions. Neurogastroenterol Motil 2018;30:e13238. [DOI: 10.1111/nmo.13238] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
72 Melchior C, Douard V, Coëffier M, Gourcerol G. Fructose and irritable bowel syndrome. Nutr Res Rev 2020;33:235-43. [PMID: 32122419 DOI: 10.1017/S0954422420000025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
73 Cox SR, Lindsay JO, Fromentin S, Stagg AJ, Mccarthy NE, Galleron N, Ibraim SB, Roume H, Levenez F, Pons N, Maziers N, Lomer MC, Ehrlich SD, Irving PM, Whelan K. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial. Gastroenterology 2020;158:176-188.e7. [DOI: 10.1053/j.gastro.2019.09.024] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 34.5] [Reference Citation Analysis]
74 Kim B, Choi HN, Yim JE. Effect of Diet on the Gut Microbiota Associated with Obesity. J Obes Metab Syndr 2019;28:216-24. [PMID: 31909364 DOI: 10.7570/jomes.2019.28.4.216] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
75 Rajindrajith S, Zeevenhooven J, Devanarayana NM, Perera BJC, Benninga MA. Functional abdominal pain disorders in children. Expert Review of Gastroenterology & Hepatology 2018;12:369-90. [DOI: 10.1080/17474124.2018.1438188] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
76 Jiang Y, Jarr K, Layton C, Gardner CD, Ashouri JF, Abreu MT, Sinha SR. Therapeutic Implications of Diet in Inflammatory Bowel Disease and Related Immune-Mediated Inflammatory Diseases. Nutrients 2021;13:890. [PMID: 33801883 DOI: 10.3390/nu13030890] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Mezzomo TR, Sampaio IR, Fiori LS, Schieferdecker MEM. Content of Poorly Absorbed Short-Chain Carbohydrates (FODMAP) in Enteral Homemade Diets. Nutrition in Clinical Practice 2019;34:264-71. [DOI: 10.1002/ncp.10223] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
78 Mehtab W, Agarwal A, Singh N, Malhotra A, Makharia GK. All that a physician should know about FODMAPs. Indian J Gastroenterol 2019;38:378-90. [PMID: 31802437 DOI: 10.1007/s12664-019-01002-0] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
79 Rahman MM, Mahadeva S, Ghoshal UC. Epidemiological and clinical perspectives on irritable bowel syndrome in India, Bangladesh and Malaysia: A review. World J Gastroenterol 2017; 23(37): 6788-6801 [PMID: 29085223 DOI: 10.3748/wjg.v23.i37.6788] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
80 Vulevic J, Tzortzis G, Juric A, Gibson GR. Effect of a prebiotic galactooligosaccharide mixture (B-GOS®) on gastrointestinal symptoms in adults selected from a general population who suffer with bloating, abdominal pain, or flatulence. Neurogastroenterol Motil 2018;30:e13440. [DOI: 10.1111/nmo.13440] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
81 Yu LM, Weng MN, Chen HJ, Ye W, Fan YH. Study of efficacy and mechanism of low FODMAPs diet on diarrhea-type irritable bowel syndrome based on a gut microbiota-dependent metabolite. Shijie Huaren Xiaohua Zazhi 2021; 29(24): 1421-1427 [DOI: 10.11569/wcjd.v29.i24.1421] [Reference Citation Analysis]
82 Fukui H, Nishida A, Matsuda S, Kira F, Watanabe S, Kuriyama M, Kawakami K, Aikawa Y, Oda N, Arai K, Matsunaga A, Nonaka M, Nakai K, Shinmura W, Matsumoto M, Morishita S, Takeda AK, Miwa H. Usefulness of Machine Learning-Based Gut Microbiome Analysis for Identifying Patients with Irritable Bowels Syndrome. J Clin Med 2020;9:E2403. [PMID: 32727141 DOI: 10.3390/jcm9082403] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
83 El-Salhy M, Hatlebakk JG, Hausken T. Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones. Nutrients. 2019;11. [PMID: 31394793 DOI: 10.3390/nu11081824] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
84 Verspreet J, Soetemans L, Gargan C, Hayes M, Bastiaens L. Nutritional Profiling and Preliminary Bioactivity Screening of Five Micro-Algae Strains Cultivated in Northwest Europe. Foods 2021;10:1516. [PMID: 34359386 DOI: 10.3390/foods10071516] [Reference Citation Analysis]
85 Eetemadi A, Tagkopoulos I. Methane and fatty acid metabolism pathways are predictive of Low-FODMAP diet efficacy for patients with irritable bowel syndrome. Clin Nutr 2021;40:4414-21. [PMID: 33504454 DOI: 10.1016/j.clnu.2020.12.041] [Reference Citation Analysis]
86 Adriani A, Saracco GM, Pellicano R. Irritable bowel syndrome: a real-world picture of the USA. Minerva Gastroenterol Dietol 2019;65:79-81. [PMID: 30746926 DOI: 10.23736/S1121-421X.19.02558-3] [Reference Citation Analysis]
87 Francini-Pesenti F, Ravarotto V, Bertoldi G, Spinella P, Calò LA. Could nutritional therapy take us further in our approaches to Fabry disease? Nutrition 2020;72:110664. [PMID: 31972420 DOI: 10.1016/j.nut.2019.110664] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
88 Nilholm C, Larsson E, Sonestedt E, Roth B, Ohlsson B. Assessment of a 4-Week Starch- and Sucrose-Reduced Diet and Its Effects on Gastrointestinal Symptoms and Inflammatory Parameters among Patients with Irritable Bowel Syndrome. Nutrients 2021;13:416. [PMID: 33525489 DOI: 10.3390/nu13020416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
89 Vakil N. Dietary Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAPs) and Gastrointestinal Disease. Nutr Clin Pract 2018;33:468-75. [PMID: 29870082 DOI: 10.1002/ncp.10108] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
90 Caputo F, Lungaro L, Galdi A, Zoli E, Giancola F, Caio G, De Giorgio R, Zoli G. Gastrointestinal Involvement in Anderson-Fabry Disease: A Narrative Review. Int J Environ Res Public Health 2021;18:3320. [PMID: 33807115 DOI: 10.3390/ijerph18063320] [Reference Citation Analysis]
91 Benjak Horvat I, Gobin I, Kresović A, Hauser G. How can probiotic improve irritable bowel syndrome symptoms? World J Gastrointest Surg 2021; 13(9): 923-940 [PMID: 34621470 DOI: 10.4240/wjgs.v13.i9.923] [Reference Citation Analysis]
92 Nightingale S, Sharma A. Functional gastrointestinal disorders in children: What is new? J Paediatr Child Health 2020;56:1724-30. [PMID: 32468619 DOI: 10.1111/jpc.14857] [Reference Citation Analysis]
93 Carubbi F, Barbato A, Burlina AB, Francini F, Mignani R, Pegoraro E, Landini L, De Danieli G, Bruni S, Strazzullo P; Italian Society of Human Nutrition Working Group on Nutrition in Lysosomal Storage Diseases. Nutrition in adult patients with selected lysosomal storage diseases. Nutr Metab Cardiovasc Dis 2021;31:733-44. [PMID: 33589321 DOI: 10.1016/j.numecd.2020.11.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
94 Staudacher HM, Ralph FS, Irving PM, Whelan K, Lomer MC. Nutrient Intake, Diet Quality, and Diet Diversity in Irritable Bowel Syndrome and the Impact of the Low FODMAP Diet. Journal of the Academy of Nutrition and Dietetics 2020;120:535-47. [DOI: 10.1016/j.jand.2019.01.017] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 14.5] [Reference Citation Analysis]
95 Biesiekierski JR, Jalanka J, Staudacher HM. Can Gut Microbiota Composition Predict Response to Dietary Treatments? Nutrients 2019;11:E1134. [PMID: 31121812 DOI: 10.3390/nu11051134] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
96 Grammatikopoulou MG, Goulis DG, Gkiouras K, Nigdelis MP, Papageorgiou ST, Papamitsou T, Forbes A, Bogdanos DP. Low FODMAP Diet for Functional Gastrointestinal Symptoms in Quiescent Inflammatory Bowel Disease: A Systematic Review of Randomized Controlled Trials. Nutrients 2020;12:E3648. [PMID: 33260902 DOI: 10.3390/nu12123648] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
97 Canakis A, Haroon M, Weber HC. Irritable bowel syndrome and gut microbiota. Current Opinion in Endocrinology, Diabetes & Obesity 2020;27:28-35. [DOI: 10.1097/med.0000000000000523] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
98 Usai-satta P, Lai M, Oppia F. Lactose Malabsorption and Presumed Related Disorders: A Review of Current Evidence. Nutrients 2022;14:584. [DOI: 10.3390/nu14030584] [Reference Citation Analysis]
99 Manning LP, Biesiekierski JR. Use of dietary interventions for functional gastrointestinal disorders. Current Opinion in Pharmacology 2018;43:132-8. [DOI: 10.1016/j.coph.2018.09.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
100 Brunkwall L, Ericson U, Nilsson PM, Orho-Melander M, Ohlsson B. Self-reported bowel symptoms are associated with differences in overall gut microbiota composition and enrichment of Blautia in a population-based cohort. J Gastroenterol Hepatol 2021;36:174-80. [PMID: 32428346 DOI: 10.1111/jgh.15104] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
101 Qu L, Shi K, Xu J, Liu C, Ke C, Zhan X, Xu K, Liu Y. Atractylenolide-1 targets SPHK1 and B4GALT2 to regulate intestinal metabolism and flora composition to improve inflammation in mice with colitis. Phytomedicine 2022;98:153945. [PMID: 35114452 DOI: 10.1016/j.phymed.2022.153945] [Reference Citation Analysis]
102 Nybacka S, Törnblom H, Simren M, Störsrud S. The Role of Carbohydrates in Irritable Bowel Syndrome: Protocol for a Randomized Controlled Trial Comparing Three Different Treatment Options. JMIR Res Protoc 2022;11:e31413. [PMID: 35037893 DOI: 10.2196/31413] [Reference Citation Analysis]
103 Coutts A. Nursing management of irritable bowel syndrome. Nursing Standard 2019;34:76-81. [DOI: 10.7748/ns.2019.e11363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
104 Chen BR, Du LJ, He HQ, Kim JJ, Zhao Y, Zhang YW, Luo L, Dai N. Fructo-oligosaccharide intensifies visceral hypersensitivity and intestinal inflammation in a stress-induced irritable bowel syndrome mouse model. World J Gastroenterol 2017; 23(47): 8321-8333 [PMID: 29307992 DOI: 10.3748/wjg.v23.i47.8321] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
105 Dolan R, Chey WD, Eswaran S. The role of diet in the management of irritable bowel syndrome: a focus on FODMAPs. Expert Rev Gastroenterol Hepatol 2018;12:607-15. [PMID: 29764234 DOI: 10.1080/17474124.2018.1476138] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
106 Laatikainen R, Salmenkari H, Sibakov T, Vapaatalo H, Turpeinen A. Randomised Controlled Trial: Partial Hydrolysation of Casein Protein in Milk Decreases Gastrointestinal Symptoms in Subjects with Functional Gastrointestinal Disorders. Nutrients 2020;12:E2140. [PMID: 32708428 DOI: 10.3390/nu12072140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
107 Schindler V, Giezendanner S, Van Oudenhove L, Murray FR, Buehler J, Bordier V, Hente J, Pohl D. Better response to low FODMAP diet in disorders of gut-brain interaction patients with pronounced hydrogen response to a nutrient challenge test. J Gastroenterol Hepatol 2021. [PMID: 34107550 DOI: 10.1111/jgh.15573] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
108 Peng Z, Yi J, Liu X. A Low-FODMAP Diet Provides Benefits for Functional Gastrointestinal Symptoms but Not for Improving Stool Consistency and Mucosal Inflammation in IBD: A Systematic Review and Meta-Analysis. Nutrients 2022;14:2072. [DOI: 10.3390/nu14102072] [Reference Citation Analysis]
109 van Odijk J, Lindqvist HM. Milk- and wheat protein drinks for double blind placebo controlled food challenge in adults: a simple tool for diagnosis. Clin Transl Allergy 2019;9:46. [PMID: 31548879 DOI: 10.1186/s13601-019-0284-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
110 Khlevner J, Park Y, Margolis KG. Brain-Gut Axis: Clinical Implications. Gastroenterol Clin North Am 2018;47:727-39. [PMID: 30337029 DOI: 10.1016/j.gtc.2018.07.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
111 Verbeke K. Combining dietary fibres to reduce intestinal gas production in patients with IBS. Gut 2021:gutjnl-2021-325618. [PMID: 34556522 DOI: 10.1136/gutjnl-2021-325618] [Reference Citation Analysis]
112 Mullish BH, Quraishi MN, Segal JP, Ianiro G, Iqbal TH. The gut microbiome: what every gastroenterologist needs to know. Frontline Gastroenterol 2021;12:118-27. [PMID: 33613943 DOI: 10.1136/flgastro-2019-101376] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
113 El-Salhy M, Patcharatrakul T, Gonlachanvit S. The role of diet in the pathophysiology and management of irritable bowel syndrome. Indian J Gastroenterol 2021;40:111-9. [PMID: 33666892 DOI: 10.1007/s12664-020-01144-6] [Reference Citation Analysis]
114 Dimidi E, Whelan K. Food supplements and diet as treatment options in irritable bowel syndrome. Neurogastroenterol Motil 2020;32:e13951. [PMID: 32697018 DOI: 10.1111/nmo.13951] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
115 Krieger-Grübel C, Hutter S, Hiestand M, Brenner I, Güsewell S, Borovicka J. Treatment efficacy of a low FODMAP diet compared to a low lactose diet in IBS patients: A randomized, cross-over designed study. Clin Nutr ESPEN 2020;40:83-9. [PMID: 33183577 DOI: 10.1016/j.clnesp.2020.09.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
116 Miranda J, Vázquez-Polo M, Pérez-Junkera G, Fernández-Gil MDP, Bustamante MÁ, Navarro V, Simón E, Martínez O. FODMAP Intake in Spanish Population: Open Approach for Risk Assessment. Int J Environ Res Public Health 2020;17:E5882. [PMID: 32823689 DOI: 10.3390/ijerph17165882] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
117 Chai YN, Qin J, Li YL, Tong YL, Liu GH, Wang XR, Liu CY, Peng MH, Qin CZ, Xing YR. TMT proteomics analysis of intestinal tissue from patients of irritable bowel syndrome with diarrhea: Implications for multiple nutrient ingestion abnormality. J Proteomics 2021;231:103995. [PMID: 33011346 DOI: 10.1016/j.jprot.2020.103995] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
118 Jeitler M, Wottke T, Schumann D, Puerto Valencia LM, Michalsen A, Steckhan N, Mittwede M, Stapelfeldt E, Koppold-Liebscher D, Cramer H, Wischnewsky M, Murthy V, Kessler CS. Ayurvedic vs. Conventional Nutritional Therapy Including Low-FODMAP Diet for Patients With Irritable Bowel Syndrome-A Randomized Controlled Trial. Front Med (Lausanne) 2021;8:622029. [PMID: 34552937 DOI: 10.3389/fmed.2021.622029] [Reference Citation Analysis]
119 Bellini M, Tonarelli S, Barracca F, Morganti R, Pancetti A, Bertani L, de Bortoli N, Costa F, Mosca M, Marchi S, Rossi A. A Low-FODMAP Diet for Irritable Bowel Syndrome: Some Answers to the Doubts from a Long-Term Follow-Up. Nutrients 2020;12:E2360. [PMID: 32784614 DOI: 10.3390/nu12082360] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
120 Remes-Troche JM, Taboada-Liceaga H, Gill S, Amieva-Balmori M, Rossi M, Hernández-Ramírez G, García-Mazcorro JF, Whelan K. Nopal fiber (Opuntia ficus-indica) improves symptoms in irritable bowel syndrome in the short term: a randomized controlled trial. Neurogastroenterol Motil 2021;33:e13986. [PMID: 32935904 DOI: 10.1111/nmo.13986] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Dahl WJ, Alvarez MM. Whole Pulses and Pulse Fiber: Modulating Gastrointestinal Function and the Microbiome. In: Dahl WJ, editor. Health Benefits of Pulses. Cham: Springer International Publishing; 2019. pp. 91-108. [DOI: 10.1007/978-3-030-12763-3_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
122 Usai-Satta P, Oppia F, Lai M, Cabras F. Hydrogen Breath Tests: Are They Really Useful in the Nutritional Management of Digestive Disease? Nutrients 2021;13:974. [PMID: 33802839 DOI: 10.3390/nu13030974] [Reference Citation Analysis]
123 Alessandria C, Caviglia GP, Campion D, Nalbone F, Sanna C, Musso A, Abate ML, Rizzetto M, Saracco GM, Balzola F. HLA-DQ Genotyping, Duodenal Histology, and Response to Exclusion Diet in Autistic Children With Gastrointestinal Symptoms. Journal of Pediatric Gastroenterology & Nutrition 2019;69:39-44. [DOI: 10.1097/mpg.0000000000002293] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
124 Lockyer S, Spiro A. The role of bread in the UK diet: An update. Nutr Bull 2020;45:133-64. [DOI: 10.1111/nbu.12435] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
125 Seamark L, Barclay Y, Marchant C, Williams M, Hickson M. Long-term symptom severity in people with irritable bowel syndrome following dietetic treatment in primary care: A service evaluation. J Hum Nutr Diet 2021;34:890-900. [PMID: 33761153 DOI: 10.1111/jhn.12860] [Reference Citation Analysis]
126 van Lanen AS, de Bree A, Greyling A. Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis. Eur J Nutr 2021;60:3505-22. [PMID: 33585949 DOI: 10.1007/s00394-020-02473-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
127 Schneider E, Sabaté JM, Bouchoucha M, Hercberg S, Touvier M, Benamouzig R, Julia C, Buscail C. Fermentable Oligo-, Di-, and Mono-Saccharides and Polyols (FODMAPs) Consumption and Irritable Bowel Syndrome in the French NutriNet-Santé Cohort. Nutrients 2021;13:4513. [PMID: 34960065 DOI: 10.3390/nu13124513] [Reference Citation Analysis]
128 Mari A, Abu Baker F, Mahamid M, Sbeit W, Khoury T. The Evolving Role of Gut Microbiota in the Management of Irritable Bowel Syndrome: An Overview of the Current Knowledge. J Clin Med 2020;9:E685. [PMID: 32143424 DOI: 10.3390/jcm9030685] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
129 Shin SY, Cha BK, Kim WS, Park JY, Kim JW, Choi CH. The Effect of Phloroglucinol in Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled Trial. J Neurogastroenterol Motil 2020;26:117-27. [PMID: 31917916 DOI: 10.5056/jnm19160] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
130 Cyrkot S, Marcon M, Brill H, Mileski H, Dowhaniuk J, Frankish A, Carroll MW, Persad R, Turner JM, Mager DR. FODMAP intake in children with coeliac disease influences diet quality and health-related quality of life and has no impact on gastrointestinal symptoms. Int J Food Sci Nutr 2021;:1-12. [PMID: 33541165 DOI: 10.1080/09637486.2021.1880553] [Reference Citation Analysis]
131 Tondt J, Yancy WS, Westman EC. Application of nutrient essentiality criteria to dietary carbohydrates. Nutr Res Rev 2020;33:260-70. [PMID: 32102704 DOI: 10.1017/S0954422420000050] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]